Who has been buying icure stock?

1 distinct insiders have filed 1 disclosed insider purchases in icure (175250), most recently on 2025-03-31. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does icure have?

icure has 1 buy-side and 0 sell-side disclosures on record, covering ₩7M ($5K) in total reported value, spanning 2024-05-21 to 2025-03-31.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

icure 175250

Company

아이큐어icure

Insiders

Buys

Total Value

₩7M ($5K)

Avg Return

+17.36%

Last Filing

2025-03-31

icure (175250) has 1 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩7M ($5K) in reported transaction value. The earliest filing StockDrifts holds for icure is dated 2024-05-21; the most recent is 2025-03-31. Across these filings the average return since disclosure is +17.36%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2026-09-11	BUY	Market Buy	김성수 Seongsu Kim	moving	6	₩1,833	-5.8%	₩11K ($7)
2026-09-10	BUY	Market Buy	차윤상 Cha Yun-sang	Managing Director	1.0K	₩1,823	-5.3%	₩2M ($1K)
2026-09-09	BUY	Market Buy	차윤상 Cha Yun-sang	Managing Director	200	₩1,791	-3.6%	₩393K ($273)
2026-09-08	BUY	Market Buy	안영균 Youngkyun Ahn	moving	900	₩1,791	-3.6%	₩2M ($1K)
2026-09-08	BUY	Market Buy	최영종 Youngjong Choi	moving	1.0K	₩1,791	-3.6%	₩2M ($1K)
2026-09-08	BUY	Market Buy	차윤상 Cha Yun-sang	Managing Director	300	₩1,791	-3.6%	₩573K ($398)
2026-09-07	BUY	Market Buy	차윤상 Cha Yun-sang	Managing Director	500	₩1,791	-3.6%	₩1M ($951)
2026-09-07	BUY	Market Buy	안영균 Youngkyun Ahn	moving	1.1K	₩1,791	-3.6%	₩3M ($2K)
2026-08-29	BUY	제3자배정유상증자	솔루엠코스메틱 SoluM Cosmetic	-	18.9M	₩2,870	-26.8%	₩19.5B ($13.5M)
2025-03-31	SELL	임원퇴임	박종전 Park Jong-jeon	vice president	-1.7K	₩1,558	-39.3%	₩3M ($2K)
2024-05-21	BUY	Market Buy	이영석 Youngseok Lee	CEO	3.6K	₩1,849	+17.4%	₩7M ($5K)
2023-01-04	BUY	무상신주취득	김성수 Seongsu Kim	moving	544	-	-	-

Frequently asked questions

Who has been buying icure stock?: 1 distinct insiders have filed 1 disclosed insider purchases in icure (175250), most recently on 2025-03-31. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does icure have?: icure has 1 buy-side and 0 sell-side disclosures on record, covering ₩7M ($5K) in total reported value, spanning 2024-05-21 to 2025-03-31.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.